0001651308-24-000069.txt : 20240607
0001651308-24-000069.hdr.sgml : 20240607
20240607170524
ACCESSION NUMBER: 0001651308-24-000069
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240605
FILED AS OF DATE: 20240607
DATE AS OF CHANGE: 20240607
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Ball Titus B.
CENTRAL INDEX KEY: 0001675628
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37686
FILM NUMBER: 241030544
MAIL ADDRESS:
STREET 1: 11605 NORTH COMMUNITY HOUSE ROAD
STREET 2: SUITE 600
CITY: CHARLOTTE
STATE: NC
ZIP: 28277
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BeiGene, Ltd.
CENTRAL INDEX KEY: 0001651308
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 981209416
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: C/O MOURANT GOVERNANCE SERVICES (CAYMAN)
STREET 2: 94 SOLARIS AVENUE, CAMANA BAY
CITY: GRAND CAYMAN
STATE: E9
ZIP: KY1-1108
BUSINESS PHONE: 13459494123
MAIL ADDRESS:
STREET 1: C/O MOURANT GOVERNANCE SERVICES (CAYMAN)
STREET 2: 94 SOLARIS AVENUE, CAMANA BAY
CITY: GRAND CAYMAN
STATE: E9
ZIP: KY1-1108
4
1
wk-form4_1717794316.xml
FORM 4
X0508
4
2024-06-05
0
0001651308
BeiGene, Ltd.
BGNE
0001675628
Ball Titus B.
C/O MOURANT GOVERNANCE SERVICES (CAYMAN)
94 SOLARIS AVENUE
CAMANA BAY, GRAND CAYMAN
E9
KY1-1108
CAYMAN ISLANDS
0
1
0
0
Principal Accounting Officer
0
Ordinary Shares
2024-06-05
4
A
0
24427
0
A
47905
D
Share Option (Right to Buy)
12.23
2024-06-05
4
A
0
15340
0
A
2034-06-04
Ordinary Shares
15340
15340
D
Represents securities underlying restricted share units. 1/4th of the securities will vest on each anniversary of June 5, 2024, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events.
The number of securities underlying each option and the exercise price therefor are represented in ordinary shares. Each American Depositary Share represents 13 ordinary shares.
These securities vest over a four-year period as follows: 25% on the first anniversary of June 5, 2024 with the remaining shares vesting in 36 equal successive monthly installments thereafter, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events.
/s/ Qing Nian, as Attorney-in-Fact
2024-06-07